Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 study comparing pharmacokinetics and safety of a single oral dose of BR3006 versus co-administration with BR3006A, BR3006B and BR3006C in healthy adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BR3006
• BR3006A
• BR3006B
• BR3006C

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED